There is no fixed limit on the number of chemotherapy needed for bile duct cancer, it can be done 4~6 times, or the number can be increased or decreased according to the actual condition of the patient, the patient’s response to chemotherapy, and the patient’s general condition.
Cholangiocarcinoma belongs to malignant tumor, which is mainly treated by surgery and has limited sensitivity to radiotherapy. Some patients who cannot be operated, have better general status, or have high risk factors for recurrence and metastasis after operation can take chemotherapy, and malignant tumors are routinely treated with chemotherapy for 4~6 times, with efficacy evaluation done every 2 times, and the treatment plan adjusted according to the situation.
There are various clinical situations, for example, some cholangiocarcinoma patients have poor general status, or accompanied with basic diseases such as liver and kidney, which affects the tolerance of chemotherapy, doctors will reduce the number of chemotherapy sessions and chemotherapy dosage according to the situation, and some patients have poor response to chemotherapy, and it is possible that they can change to targeted therapy or immunotherapy after doing chemotherapy for 2 sessions.
The number of chemotherapy treatments for cholangiocarcinoma should be formulated by specialists according to the actual situation of patients and should not be generalized. It is recommended that patients should go to regular hospitals and seek professional doctors to consult and evaluate their conditions and follow the doctor’s instructions.